Overview
- Editors:
-
-
Andrew Arnold
-
Laboratory of Endocrine Oncology Massachusetts General Hospital, Harvard Medical School, Boston, USA
Access this book
Other ways to access
Table of contents (20 chapters)
-
-
- Ilan Shimon, Shlomo Melmed
Pages 1-24
-
- Giovanni Cizza, George P. Chrousos
Pages 25-40
-
- Laurence Katznelson, Anne Klibanski
Pages 41-55
-
-
-
- Stefan K. G. Grebe, Ian D. Hay
Pages 91-140
-
- Arthur B. Schneider, Leon Fogelfeld
Pages 141-161
-
-
-
- David Goltzman, Janet E. Henderson
Pages 193-215
-
- Ana C. Latronico, George P. Chrousos
Pages 217-237
-
-
- Richard T. Kloos, Melvyn Korobkin, Norman W. Thompson, Isaac R. Francis, Brahm Shapiro, Milton D. Gross
Pages 263-292
-
-
-
- Pamela M. Thomas, Gilbert J. Cote
Pages 347-363
-
- L. J. Hofland, S. W. J. Lamberts
Pages 365-382
-
-
About this book
Andrew Arnold The past several years have been a time of intense excitement and have brought major advances in the understanding and treatment of endocrine neoplasms. This is therefore an excellent point at which to undertake a broad based overview of the state of the art in endocrine neoplasia for the Cancer Treatment and Research series. Because of the wide and interdisciplinary readership of this series, our aim for each chapter has been to provide ample background for those not highly familiar with the topic, while emphasizing the most recent advances. Furthermore, the chapters have been written with the clinician in mind, whether she or he is an oncologist, endocrinologist, surgeon, generalist, pathologist, or radiologist. As such, the authors' mission has been to focus on clinically relevant issues and to present the scientific basis of current or potential future advances in a manner easily digestible to the nonexpert. Endocrine tumors often cause problems for the patient by virtue of their hormonal activity, which may frequently (but certainly not always) over shadow the adverse consequences related to their mass per se. In fact, it is important to keep in mind that endocrine tumors can manifest two biologically separable but often intertwined properties, namely, increased cell mass and abnormal hormonal function. These need not go hand in hand, and their distinction has definite clinical relevance in, for example, the increasingly recognized problem of incidentally discovered adrenal or pituitary masses.
Editors and Affiliations
-
Laboratory of Endocrine Oncology Massachusetts General Hospital, Harvard Medical School, Boston, USA
Andrew Arnold
